Get started
Novartis AG (NOVN.vx) bearish scenario:The technical figure Triangle can be found in the Swiss company Novartis International AG (NOVN.vx) at daily chart. Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; production ceased 2020), terbinafine (Lamisil), deferasirox (Exjade), and others. The Triangle has broken through the support line on 03/05/2022, if the price holds below this level you can have a possible bearish price movement with a forecast for the next 12 days towards 80.160 CHF. Your stop loss order according to experts should be placed at 87.480 CHF if you decide to enter this position. Novartis said earnings and sales rose in the first quarter of the year, boosted by its key drugs, including heart failure treatment Entresto. Net income was $2.2 billion, up from $1.8 billion in the same quarter the previous year, on sales that grew to $12.53 billion from $12.41 billion. Analysts expected sales of $12.62 billion. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
SIX:NOVNShort
by legacyFXofficial
2
Nestle Europe Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
SIX:NESN
by Sunstorminvest
Novartis (NOVN.vx) bullish scenario:The technical figure Double Bottom can be found in the Swiss company Novartis International AG (NOVN.vx) at daily chart. Novartis International AG is a Swiss multinational pharmaceutical corporation. It is one of the largest pharmaceutical companies in the world. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), deferasirox (Exjade), and others. The Double Bottom has broken through the resistance line on 07/04/2022, if the price holds above this level you can have a possible bullish price movement with a forecast for the next 29 days towards 86.88 CHF. Your stop-loss order according to experts should be placed at 72.50 CHF if you decide to enter this position. Novartis CEO Vas Narasimhan is continuing his shake-up of the giant Swiss drugmaker, announcing a corporate restructuring on Monday that the company says will simplify its organizational chart and bring more than $1 billion in annual savings. Novartis AG NVS announced that the FDA has approved its kinase inhibitor, Vijoice (alpelisib), for the treatment of patients aged two years and above with severe manifestations of PIK3CA-Related Overgrowth Spectrum (“PROS”), requiring systemic therapy. Per the company, following the nod, Vijoice became the first FDA-approved therapy to treat PROS, which includes rare conditions where overgrowths and blood vessel anomalies occur. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
SIX:NOVNLong
by legacyFXofficial
FHZN - The power of elliot waves | Volume 2The zurich airport is tough, but in the coming months this toughness will be tested once again! SIX:FHZN Our last analysis on this share was published on January 12, in which we warned about a potential sell-off. In this analysis we highlighted the importance of the wedge formation to our subscribers. In the last days the stock fell by more than -20% and we have now left this formation. Today zurich airport published its earnings and based on them we can evaluate the progress of the company. The airport was able to slightly reduce its net loss in the past year but disappointed investors with lower revenues than expected . Revenues were just under 680 million , which is about half of what they were before the Corona crisis. The management announced that a full recovery to the pre-crisis level of 2019 is not expected until the end of 2025. Investors will have to be patient with the company and as most assumed there won't be a dividend payout again this year. This however gives the management the opportunity to direct the money to where it's most needed. Overall, the airport is recovering in small steps from the shock of the Corona crisis. The upcoming years will bring further difficulties, but the management will concentrate on navigating the company back to profitability. Technical explanation of the elliot wave structure: As mentioned above, the share price has fallen by almost -20% since we last warned of a sell-off. We as Mendenmein Capital see this as another confirmation of our calculations. Nevertheless, we assume that the share has now expanded a first downward impulse in the white wave (1) and in the coming weeks a slight recovery must be expected in the white wave (2). This wave will lay the foundation for further sell-offs and the target for the next year is located at just 95 swiss francs. The white wave (3) should be able to reach this target without any problems. After a short recovery in the white wave (4), a final wave (5) will continue to correct towards our final target of 80 swiss francs. We assume that this downward impulse will occupy us in the coming months and years. In the long term however, we are extremely bullish and the formations of the last years point towards a very large wave I / wave II super cycle. This means that we have a multi-year bull market ahead of us after the completion of wave II, our subscribers are familiar with this term by now. The long-term price target for this stock is 450.- and we at Mendenmein Capital are extremely confident in our optimistic views. On our website investors can learn more about the zurich airport share and other stocks! www.mendenmein-capital.com Disclaimer: According to legal regulations, Mornau-Research is not a certified or legally recognized financial advisor and any transactions based on published content are at your own risk. Mornau-Research cannot be held liable for any losses whatsoever according to the legal regulations in it's country of residence. =============================================================================================================== If you have questions related to a specific stock or the Elliot Wave theory, feel free to contact us.
SIX:FHZNEducation
by Mendenmein-Capital
FHZN - The power of elliot waves Dear subscribers, lets come together for an educational article featuring the zurich airport. SIX:FHZN We have published some articles about the Zurich Airport in the past and suspected back then a more bullish structure than this one which we are publishing now. The Zurich Airport company operates and manages the eponymous Zurich Airport in Switzerland, which is the international transportation hub for the entire country. The company has an excellent management and the government of Zurich itself holds almost 38.38% of all shares. Therefore, Zurich Airport can always rely on government support and enjoys a good reputation. In addition, the company is increasingly expanding into emerging markets and now owns Hercilio Luz Airport (FLN) in Florianopolis Brazil. For the future, it is therefore clear that the company is increasingly driving its presence abroad and expanding its business model. However, the zurich airport stock provides an excellent example to introduce traders who are not familiar with the Elliot Wave method of analysis. The stock has originally been around since 2000, but on Tradingview we only have access to the market data since the beginning of 2010, but this makes little difference to the current movement, as a huge 1-2 wave setup was also formed during the period 2000-2010. Technical explanation of the Elliot wave structure: The stock has experienced a huge price increase since 2012, which was supported based on a huge 1-2 (Orange) wave setup. From this structure, a large wave 3 was established, which additonally established a complete impulse of its own (dark green). After completing a short correction in wave 4, the stock first formed an impulse (light green) and ended the year-long bull market with a final impulse (turquoise) Since then, we have seen a very hard downward impulse, which reached its absolute peak in early 2020 due to the Corona crisis. Since the last low at just under $83, the stock has been rising again in what we categorized as a wave B (yellow). Now, a wedge has formed over the last two years, which strengthens our assumption of a corrective B wave. Finally, a breakout can be expected within the year 2022 and the stocj will correct with high probability back to 80$. Disclaimer: According to legal regulations, Mornau-Research is not a certified or legally recognized financial advisor and any transactions based on published content are at your own risk. Mornau-Research cannot be held liable for any losses whatsoever according to the legal regulations in it's country of residence. =============================================================================================================== If you have questions related to a specific stock or the Elliot Wave theory, feel free to contact us.
SIX:FHZNEducation
by Mendenmein-Capital
Monthly OutlookThe social networking company Facebook, Inc. held its initial public offering (IPO) on Friday, May 18, 2012. The IPO was the biggest in technology and one of the biggest in Internet history, with a peak market capitalization of over $104 billion. The low (63.77) at January, 2015, is due to the data provided by the Broker. Facebook grew really fast, unlike other Technology Companies that grew gradually and steadily, thus it the stock falls fast as well, due to stock exchange, technical, economic activities and other factors. If the stock can ever get to 138, I don't mind buying the dip and hold for a decade, lol.
SIX:FB
by oceantutor1